Search results
Results From The WOW.Com Content Network
He then served as a fellow in hematology–oncology at Memorial Sloan Kettering Cancer Center in Manhattan until 1999. Fata was an attending physician at Geisinger Medical Center in Danville, Pennsylvania, from 2000 to 2003. Fata struck out on his own in 2003, opening Michigan Hematology–Oncology (MHO) in Rochester Hills, Michigan.
Hematology/Oncology: as of 2005, there were 125 ACGME-accredited programs for Hematology-Oncology, while only 12 programs for Hematology alone and 18 for Oncology alone. Geriatrics/Oncology: the American Board of Internal Medicine approved a 3-year combined fellowship training program in medical oncology and geriatrics. The John A. Hartford ...
Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers.
2: 0: 0: 0: 4: 2: Pages in category "List-Class hematology-oncology articles" The following 23 pages are in this category, out of 23 total.
The American Society of Hematology (ASH) is a professional organization representing hematologists, founded in 1958. Its annual meeting is held in December of every year and has attracted more than 30,000 attendees. [ 1 ]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Seattle Cancer Care Alliance (SCCA) is a cancer treatment and research center in Seattle, Washington.Established in 1998, this nonprofit provides clinical oncology care for patients treated at its three partner organizations: Fred Hutchinson Cancer Research Center, Seattle Children's and UW Medicine. [1]
American Journal of Hematology is an academic journal devoted to the coverage of blood diseases. It has been published since 1976. The editor-in-chief is Carlo Brugnara (Harvard Medical School). [1] According to the Journal Citation Reports, the journal has a 2022 impact factor of 12.8, ranking it 7th out of 76 journals in the category ...